Next Article in Journal
A Review of Hand Function Rehabilitation Systems Based on Hand Motion Recognition Devices and Artificial Intelligence
Previous Article in Journal
The Effect of Ticagrelor for Endovascular Intervention of Intracranial Aneurysm Patients with or without Clopidogrel Resistant: A Meta-Analysis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Voxel-Mirrored Homotopic Connectivity Is Altered in Meibomian Gland Dysfunction Patients That Are Morbidly Obese

1
Department of Ophthalmology, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China
2
Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong 999077, China
3
Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA 02114, USA
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Brain Sci. 2022, 12(8), 1078; https://doi.org/10.3390/brainsci12081078
Submission received: 7 April 2022 / Revised: 14 June 2022 / Accepted: 21 July 2022 / Published: 15 August 2022
(This article belongs to the Section Behavioral Neuroscience)

Abstract

:
Purpose: To investigate the altered functional connectivity (FC) of the cerebral hemispheres in patients with morbid obesity (MO) with meibomian gland dysfunction (MGD) by voxel-mirrored homotopic connectivity (VMHC). Methods: Patients and matched healthy controls (HCs) were recruited, and all subjects underwent functional resonance magnetic imaging (fMRI), and VMHC results were processed statistically to assess the differences in FC in different brain regions between the two groups. We further used ROC curves to evaluate the diagnostic value of these differences. We also used Pearson’s correlation analysis to explore the relationship between changes in VMHC values in specific brain regions, visual acuity, and Mini-Mental State Examination (MMSE) score. Conclusions: Patients with morbid obesity and MGD had abnormal FC in the cerebral hemispheres in several specific brain areas, which were mainly concentrated in pathways related to vision and perception and may correlate to some extent with the clinical presentations of the patients.

1. Introduction

Obesity has become a global health issue. The body mass index (BMI) is widely used in clinical practice to diagnose obesity in patients as well as the degree of obesity. Ideally, individuals should maintain a BMI of 18.5 to 24.9 kg/m2 and a BMI of ≥25 kg/m2 is defined as obese. When the BMI ≥ 37.5 kg/m2, a subtotal gastrectomy to avoid further metabolic disturbances may be necessary [1]. Numerous studies have shown that severe obesity is a clear risk factor for many diseases, including coronary heart disease [2], type 2 diabetes mellitus [3], hypertension [4], and stroke [5]. Obesity is particularly linked to hyperlipidemia [6]. Abnormalities in the lipid metabolism affect all organs and tissues throughout the body, and the relationship between obesity and ophthalmopathy or pathological states of the eye has received a great deal of attention. Obesity is strongly associated with cataracts [7], optic neuropathy [8], age-related macular degeneration [9], high ocular hypertension [10], and diabetic retinopathy [11]. One of the main concerns is the complication of meibomian gland dysfunction (MGD) in severely obese patients, which are characterized by obstruction of the terminal ducts of the lid gland, diffuse lesions, and chronic progression of the disease (Figure 1). MGD is affected by a number of factors, including altered hormone levels [12,13], congenital anatomical abnormalities of the lid gland [14], and chronic blepharitis [15]. Furthermore, a few studies have addressed the relationship between obesity and MGD [16] (Figure 2). A recent large sample multicenter study has provided definitive evidence of the relationship between them [17] and concluded that the association is more pronounced in young people than in the elderly. The mechanisms that establish this link are not yet clear, and the available findings so far have suggested some preliminary hypotheses, notably that: (1) high levels of saturated lipids lead to obstruction of the lid ducts [18], and (2) obesity itself, as a chronic inflammatory disease, also inhibits the anti-inflammatory response, causing elevated levels of pro-inflammatory mediators and free fatty acids in the circulatory system [19]. Further support for this hypothesis is provided by Bu et al.’s study that showed a high-fat diet leads to disruption of corneal endothelial cell pump function and cellular tight junctions [20] and observations in an animal model of excessive lipid accumulation in the lid gland alveoli, obstruction of the ductal orifice, and infiltration of inflammatory cells [21] (Figure 3).
Some fMRI-based studies have shown a degree of cognitive dysfunction in obese patients [22], who may show alterations in functional connectivity (FC) and spontaneous EEG activity in visual, emotional, and cognitive-related brain regions [23,24]. However, it is not clear whether the FC is further altered when excessive obesity is accompanied by MGD. Voxel-mirrored homotopic connectivity (VMHC) is a modern rs-fMRI-based technique that measures the strength of inter-hemispheric FC in corresponding regions of both hemispheres, and it allows assessment of the degree of inter-hemispheric functional synergy [25]. VMHC, amplitude of low frequency fluctuation (ALFF), and functional connectivity density (FCD) are all rs-fMRI-based techniques. However, unlike the other two sequences, VMHC focuses more on the ability to incorporate information exchange and functional interactions between the hemispheres [26]. VMHC has been utilized extensively in the study of a variety of ophthalmic disorders, including strabismus [27], unilateral acute open globe injury [28], corneal ulcer [29], and acute eye pain [30]. It has been demonstrated that the synchrony of neural activity in the visual cortex is closely related to visual perception [31], and the synchrony of it remains well maintained in the early monocularly deprived (MD) model [21].
In line with the above, we aimed to investigate the presence of alterations in VMHC in specific brain regions in obese patients to explore whether these alterations were tied to clinical presentations and potential ocular surface damage.

2. Methods

2.1. Participants

The inclusion of 12 samples per group in this study was determined based on a sample size of n = 15.6 R + 1.6 per group at 80% certainties. Twelve meibomian gland dysfunction patients with morbidly obese (MGD-MO) patients [30] and 12 healthy subjects (HCs) matched for their basic characteristics were identified from the First Affiliated Hospital of Nanchang University and enrolled in this study. Prior to the start of the experiment, basic information is collected on the patient, including visual acuity, blood pressure measured via mercury sphygmomanometer, and cognitive function measured via MMSE score.
All patients incorporated into the MGD-MO group had a BMI ≥ 40 kg/m2 and were diagnosed with MGD by a certified clinician. Exclusion criteria for all subjects included: (1) age < 18 years, (2) ocular surface infection from any cause that was in an active phase, (3) ocular disease such as glaucoma, strabismus, and diabetic retinopathy, (4) ocular surgery within six months, (5) medication to control lipid levels or estrogen replacement therapy for any reason, and (6) Alzheimer’s disease, Parkinson’s disease, or otherwise unable to cooperate with the examination.
This study strictly adhered to the Declaration of Helsinki and written approval was obtained from the Ethics Committee of the First Affiliated Hospital of Nanchang University prior to the commencement of the experiment. Professional staff was selected to be in charge of explaining to all subjects the purpose of the study, the content of the experiment, and the potential risks, as well as ensuring that all participants were informed.

2.2. MRI Data Collections

The first step was to obtain T1 localization scans, and all subjects underwent MRI to obtain high-resolution T1-weighted images via a three-dimensional spoiled gradient-recalled sequence. The parameters of the scans were: (thickness = 1.0 mm, repetition time = 1900 ms, acquisition matrix 256 × 256, echo time 2.26 ms, field of view: 250 × 250 mm2, gap = 0.5 mm, flip angle = 9°). During the eight-minute resting-state scans, the parameters corrected to cover the whole brain were as follows (echo time 30 ms, repetition time approximately 2000 ms, gap = 1.2 mm, thickness = 4.0 mm, acquisition matrix 64 × 64, flip angle = 90°, axial 29, a field of view = 220 × 220 mm2). For the duration of the functional MRI scan, all subjects were instructed to stay conscious and avoid deliberate thinking under the guidance of a medical professional, while maintaining their body posture immobile to avoid overthinking.

2.3. fMRI Data Preconditioning

Following fMRI scanning of all subjects and T1 images acquisition, data were analyzed with MRIcro software (www.MRIcro.com (accessed on 11 October 2021)), and preliminary data analysis was performed with SPM8 (http://www.fil.ion.ucl.ac.uk/spm (accessed on 11 October 2021)) and DPARSFA (http://rfmri.org/DPARSF (accessed on 11 October 2021)) software to complete the data pre-processing process. Some corrections; i.e., deletions, were made in order to maximize the reflection of the true situation of the experimental data, including: (1) Deleting of the data for the first five time points and only including the data for the remaining 235 time points, due to the possibility of signal instability at the initiation of the examination; (2) Head motor correction: a head immobilizer was used during the examination to minimize displacement of the subject’s head during the examination, requiring a maximum displacement of <1.5 mm in X, Y, and Z directions and a rotation angle < 3° during the scan; (3) time correction; that is, correcting for time differences during the scan to ensure that there was no theoretical difference in the time to acquire voxels at a uniform time point; and (4) spatial standardization: in consideration of the potential for subtle differences in brain volumes between subjects, a standard ultrasound image template was utilized with the study-specific symmetric Montreal Neurological Institute (MNI) as the unifying standard; (5) The images were spatially smoothed using a 6 mm full width half maximum Gaussian kernel; (6) Multiple regression methods were used to eliminate sources of artifacts; (7) Taking into account the effects of low frequency drift and high frequency noise, we improved the accuracy of the results via a temporal filter (0.01–0.08 Hz) [31].

2.4. VMHC Data Analyses

The REST software (State Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, Beijing, China) was utilized to bring the data distribution more in line with a normal distribution, specifically through Fisher z-transformation (http://restingfmri.sourceforge.net (accessed on 11 October 2021)), which transforms individual VMHCs into z-values. Individual z-plots were entered into a random effect two-sample t-test in a voxelwise manner using the overall VMHC as a covariate to determine the difference in VMHC between HCs and the MGD-MO group. (The statistical threshold was set at the voxel level with p < 0.01, alphasim was corrected, and the cluster size was >100 voxels for multiple comparisons.)

2.5. Statistical Analyses

All statistical analyses were performed via SPSS 20.0 (SPSS Inc., Chicago, IL, USA). For the section on basic patient information, independent sample t-tests were applied to quantitative data, while a chi-squared test was used for qualitative data. Results of VHMC for subjects were first tested for normality, and then independent sample t-tests were used for data that conformed to a normal distribution, while a rank-sum test was performed for data that were skewed in distribution. For all statistical analyses, a test level of α = 0.05 was used.
In addition, receiver-operating characteristic (ROC) curve analysis was carried out on brain regions with statistically significant differences in VMHC sequences between the two groups of subjects to assess the clinical value of differences in outcomes across brain regions for disease diagnosis. Second, we examined the patient’s cognitive abilities with the mini-mental state examination (MMSE) scale, and the patient’s visual acuity was also measured. The mean visual acuity of the right and left eyes was taken as the overall mean visual acuity, which was then expressed by logMAR. Finally, we assessed the relationship between subject visual acuity, MMSE score, and VMHC value in brain regions separately using Pearson’s correlation analysis via Origin 2021.

3. Results

3.1. Basic Information

There was non-statistically significant age difference (p = 0.680), gender composition (p = 0.356), systolic blood pressure (p = 0.417), and diastolic blood pressure (p = 0.112) between the two groups, while statistically significant differences were found in left eye visual acuity (p < 0.001), right eye visual acuity (p < 0.001), MMSE score (p < 0.001), and triglycerides (p = 0.045; Table 1).

3.2. VMHC Analysis Results

We computed VMHC values for both groups of ROIs and identified brain regions with differences in VMHC values between the two groups using statistical analysis. Compared to the HCs, the MGD-MO group exhibited statistically significant decreases in VMHC values in the bilateral inferior temporal gyrus (Temporal_Inf), temporal pole:middle temporal gyrus (Temporal_Pole_Mid), rolandic operculum (Rolandic_Oper), and middle temporal gyrus (Temporal-Mid), while the opposite manifestations occurred bilaterally in the anterior cingulum and paracingulate gyri (Cingulum_Ant) and the precuneus (Table 2, Figure 4).

3.3. ROC Analyses

We performed ROC analysis on the brain areas with reduced VMHC for the MGD-MO group compared to HCs to explore the diagnostic value of such alterations in clinical practice. We utilized the area under the curve (AUC) as a measure, as the AUC gives well-balanced sensitivity and specificity of diagnostic indicators. The AUCs we saw in brain regions exhibiting decreased VMHC values in MGD-MO patients were: 0.924 for Temporal-Inf, 0.979 for Temporal-Pole-Mid, 0.965 for Rolandic-Oper, and 0.951 for Temporal-Mid (Figure 5). Therefore, we believe that the VMHC value of Temporal-Pole-Mid has the greatest diagnostic value and can be used as a good indicator to distinguish MGD patients from healthy individuals.

3.4. Correlation Analyses

We carried out a correlation analysis for the brain regions with altered VMHC values and the mean visual acuity and MMSE score. MMSE score was positively correlated with the VMHC values in Temporal_Pole_Mid, Temporal_Inf, Rolandic_Oper, Tem-poral_Mid, and negatively correlated with Precuneus. Similarly, LogMAR is negatively correlated with Temporal_Pole_Mid, Temporal_Inf, Rolandic_Oper, Temporal_Mid, and positively correlated with Cingulum_Ant and Precuneus, respectively (Figure 6).

4. Discussion

The rising proportion of obese and overweight people has become a global public health issue that is gaining traction. Obesity has reached or exceeded 5% in both males and females in China, and it is still on the rise [32], raising concerns about the health risks of obesity and its complications. We chose to investigate FC changes in specific brain regions in both hemispheres of morbidly obese patients with MGD treated with VMHC.
Our data analysis revealed that VMHC changes in the MO group and HCs were primarily found in the temporal gyrus, with the MO group showing decreased FC in the Temporal-Inf, Temporal-Mid, and Temporal-Pole-Mid areas. Furthermore, the MO group experienced a decrease in VMHC values in Rolandic-Oper, while the exact opposite change was discovered in the cingulum-Ant and precuneus (Table 3).
The temporal gyrus is primarily responsible for processing auditory information and is also thought to be involved in emotion and memory; hence, abnormalities in the anatomical structure or function of the temporal gyrus can often be found in patients with epilepsy [33] or depression [34]. Specifically, Temporal-Inf is involved in a few higher perceptual processes; e.g., visual comprehension [35], and is involved in the composition of the ventral visual pathway and object recognition through vision [36], a suggestion that is strongly supported by atrophy of Temporal-Inf in Alzheimer’s disease [37]. Temporal-Pole-Mid is thought to be involved in the mapping relationship between object naming and auditory comprehension [38], but it has also been found to participate in the later period of eye presence and changes in eye gaze [39]. Temporal-Mid, on the other hand, is predominantly involved in association processes and the construction of novel and useful information [40]. Alterations in the frontal gyrus anatomy, such as spontaneous neuronal activity or FC, have been demonstrated in many diseases. Huang et al. found elevated fALFF values in the inferior temporal gyrus in patients with optic neuritis, presumably as a result of a compensatory DMN network [41]. The MO group also showed a reduction in VMHC values in the middle temporal gyrus and its visual acuity level, and statistical analysis revealed that this association was statistically significant, implying that changes in this area of FC are involved in the MGD development process and may interact with the disease. MGD can cause dry eyes as the disease progresses, and patients frequently exhibit symptoms of ocular discomfort such as photophobia, tearing, and prolonged ocular inflammation [42], but no refractive system pathology is involved, implying that this decrease in visual acuity is transient and reversible, and varies with treatment.
Traditionally, the rolandic operculum was thought to be primarily involved in linguistic processes, such as understanding the speech production [43] and encoding utterance syntax [44]. In patients with schizophrenia, Wu et al. [45] discovered increased FC between the superior temporal gyrus/posterior middle temporal gyrus and the left Rolandic-Oper, implying excessive compensatory activation of the auditory speech-priming function. The significant degeneration of the Rolandic-Oper in amyotrophic lateral sclerosis patients corresponds to the clinical manifestation of their dysarthria [46]. Furthermore, abnormalities in the Rolandic-Oper are thought to be closely linked to the pathogenesis of obsessive-compulsive disorder and the structural basis for impaired language function [47,48]. Zhang and colleagues [49] discovered a negative correlation between blood flow in the Rolandic-Oper and patients’ anxiety levels and visual acuity. Furthermore, it has been proposed that the Rolandic-Oper is heavily involved in the selective processing of conditioned threats in the visual cortex, implying that it is involved to some extent in the functional network of visually relevant pathways [50]. Thus, we discovered that the decrease in VMHC values at the Rolandic-Oper in patients with obesity and MGD may be related to patient anxiety. However, a tractography functional pathway between the Rolandic-Oper and the temporal gyrus has also been discovered [51], indicating that Rolandic-Oper alterations may also be influenced by a decreased FC in the temporal gyrus.
The Cingulum-Ant, a component of the limbic system, is widely thought to play an irreplaceable role in advanced activities, such as cognition [52], memory [53], and attention retention [54], while the dorsal anterior cingulate cortex has also been implicated in visual cognition [55]. Increased ALFF values in the cingulum were observed in patients with unilateral acute open globe injury, and this change correlated with the patient’s age, suggesting a limbic system disorder [56]. Shi et al. [57] hypothesized that the changes in gray matter values and regional homogeneity in patients with advanced monocular blindness were caused by disruptions in the synchronous activity of their neurons. Consequently, rising VMHC values of the Cingulum-Ant suggested that the patient was still in in the early stages of visual impairment and that compensatory FC activity was present in this region.
We eventually discovered that changes in VHMC values also appeared in the precuneus. The precuneus is involved in the composition of the default mode network (DMN) and as well as the composition of the visual network [58]; i.e., in the regulation of visually relevant spatial imaging and visual motion [59]. Many researchers have discovered that the precuneus exhibits grey matter volume atrophy or reduced FC in a variety of diseases, including epilepsy [60], strabismus combined with amblyopia [61], and post-herpetic neuralgia [62]. In contrast, we found that the MO group exhibited elevated precuneus FC, which means that patients may have abnormally hyperactive higher cognitive functions and visuomotor regulation, and we speculate that a compensatory change may occur early in the development of pathological changes in the eyes of the MGD-MO group (Figure 7).
In addition, it is noteworthy that some of the studies found that alterations in functional connectivity were also observed in patients with simple obesity. The study by Zhang et al. [63] observed alterations in the FC of brain regions in obese patients via amplitude of low-frequency fluctuation, but the calculation of the FC in the inferior temporal gyrus in that study yielded results opposite to ours, with the MGD possibly serving as a cause of this discrepancy, but increasing the number of subjects may lead to a different conclusion. Another review summarized research in related fields in recent years and found that the view that obesity is associated with resting-state FC is supported by the results of almost all studies, as evidenced by reduced connectivity in the DMN and emotional management related regions; increased Rs-FC between the hypothalamus and reward areas, the limbic system and the salience network, and reduced with cognitive regions [64]. These findings are broadly consistent with our research results and may further explain why we observed a significantly lower MMSE score in MGD patients than in HCs. We therefore suggest that both MO and MGD may be involved in the alteration of VMHC, and that the exact mechanisms need to be further investigated.
In summary, the alterations in VMHC values in the MGD-MO group were mainly concentrated in visual, language, emotional, and cognitive related brain areas, which may explain the clinical manifestations such as reduced visual and cognitive function that the patients experienced. To our knowledge, this is the first study to explore FC alterations in patients with MGD-MO. In addition, the altered VMHC values in specific brain regions have some value as a diagnostic basis. We also noted the presence of FC alterations in brain regions related to emotional processing and depression, suggesting that it is essential for clinicians to assess depression and anxiety in patients even if they do not present to the clinic with a depressed mood.
Ultimately, it is undeniable that our study still has some weaknesses. To begin with, the participation of too few subjects in the research remains an unavoidable drawback. In addition, as we mentioned earlier, morbid obesity itself may lead to changes in the hemispheric FC of patients, and this should be taken into account when we analyze the changes in VMHC values of patients. Therefore, we believe that further studies with larger sample sizes and more detailed subgroups are warranted.

5. Conclusions

MGD-MO patients have been observed to have abnormal hemispheric functional connectivity in brain regions related to eye movements, emotional processing and cognition, and some degree of cognitive decline. This alteration may be caused by MGD, but it cannot be ruled out that obesity itself may be involved. Altered VMHC values may serve as a valuable diagnostic indicator.

Author Contributions

Methodology, Y.-D.S. and H.-Y.S.; software, Y.S.; formal analysis, Y.-D.S. and H.-Y.S.; investigation, L.-Q.L., S.-Q.L., X.-L.L., Y.-C.P., T.S., L.-J.Z., M.K. and P.Y.; resources, Y.S.; data curation, Y.S.; writing—original draft preparation, Y.-D.S. and H.-Y.S.; writing—review and editing, Y.-D.S. and H.-Y.S.; supervision, Y.S.; project administration, Y.S.; funding acquisition, Y.S.. All authors have read and agreed to the published version of the manuscript.

Funding

National Natural Science Foundation (No: 82160195); Central Government Guides Local Science and Technology Development Foundation (No: 20211ZDG02003); Key Research Foundation of Jiangxi Province (No: 20181BBG70004, 20203BBG73059).

Institutional Review Board Statement

This study strictly adhered to the Declaration of Helsinki and written approval was obtained from the Ethics Committee of the First Affiliated Hospital of Nanchang University prior to the commencement of the experiment (ethical approval code: 2021039).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available on request from the corresponding author. The data are not publicly available due to privacy.

Acknowledgments

The authors express their sincere thanks to Yi Shao for his contribution to this article.

Conflicts of Interest

The authors have no relevant conflicts of interest to disclose.

References

  1. Demaria, E.J. Bariatric surgery for morbid obesity. N. Engl. J. Med. 2007, 356, 2176–2183. [Google Scholar] [CrossRef] [PubMed]
  2. Eckel, R.H.; Krauss, R.M. American Heart Association call to action: Obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee. Circulation 1998, 97, 2099–2100. [Google Scholar] [CrossRef]
  3. Grundy, S.M. Metabolic complications of obesity. Endocrine 2000, 13, 155–165. [Google Scholar] [CrossRef]
  4. Haslam, D.W.; James, W.P. Obesity. Lancet 2005, 366, 1197–1209. [Google Scholar] [CrossRef]
  5. Lawrence, V.J.; Kopelman, P.G. Medical consequences of obesity. J. Clin. Endocrinol. Metab. 2004, 22, 296–302. [Google Scholar] [CrossRef] [PubMed]
  6. Kuwabara, M.; Kuwabara, R.; Niwa, K.; Hisatome, I.; Smits, G.; Roncal-Jimenez, C.A.; MacLean, P.S.; Yracheta, J.M.; Ohno, M.; Lanaspa, M.A.; et al. Different Risk for Hypertension, Diabetes, Dyslipidemia, and Hyperuricemia According to Level of Body Mass Index in Japanese and American Subjects. Nutrients 2018, 10, 1011. [Google Scholar] [CrossRef]
  7. Caulfield, L.E.; West, S.K.; Barron, Y.; Cid-Ruzafa, J. Anthropometric status and cataract: The Salisbury Eye Evaluation project. Am. J. Clin. Nutr. 1999, 69, 237–242. [Google Scholar] [CrossRef] [PubMed]
  8. Bengtsson, B.; Heijl, A. A long-term prospective study of risk factors for glaucomatous visual field loss in patients with ocular hypertension. J. Glaucoma. 2005, 14, 135–138. [Google Scholar] [CrossRef] [PubMed]
  9. Delcourt, C.; Michel, F.; Colvez, A.; Lacroux, A.; Delage, M.; Vernet, M.-H. Associations of cardiovascular disease and its risk factors with age-related macular degeneration: The POLA study. Ophthalmic Epidemiol. 2001, 8, 237–249. [Google Scholar] [CrossRef] [PubMed]
  10. Bulpitt, C.J.; Hodes, C.; Everitt, M.G. Intraocular pressure and systemic blood pressure in the elderly. Br. J. Ophthalmol. 1975, 59, 717–720. [Google Scholar] [CrossRef] [PubMed]
  11. Ballard, D.J.; Melton, L.J.; Dwyer, M.S.; Trautmann, J.C.; Chu, C.-P.; O’Fallon, W.M.; Palumbo, P.J. Risk factors for diabetic retinopathy: A population-based study in Rochester, Minnesota. Diabetes Care 1986, 9, 334–342. [Google Scholar] [CrossRef] [PubMed]
  12. Perry, H.D.; Donnenfeld, E.D. Dry eye diagnosis and management in 2004. Curr. Opin. Ophthalmol. 2004, 15, 299–304. [Google Scholar] [CrossRef]
  13. Krenzer, K.L.; Dana, M.R.; Ullman, M.D.; Cermak, J.M.; Tolls, D.B.; Evans, J.E.; Sullivan, D.A. Effect of androgen deficiency on the human meibomian gland and ocular surface. J. Clin. Endocrinol. Metab. 2000, 85, 4874–4882. [Google Scholar] [CrossRef]
  14. Jastaneiah, S.; Al-Rajhi, A.A. Association of aniridia and dry eyes. Ophthalmology 2005, 112, 1535–1540. [Google Scholar] [CrossRef] [PubMed]
  15. Romero, J.M.; Biser, S.A.; Perry, H.D.; Levinson, D.H.; Doshi, S.J.; Terraciano, A.; Donnenfeld, E.D. Conservative treatment of meibomian gland dysfunction. Eye Contact Lens 2004, 30, 14–19. [Google Scholar] [CrossRef] [PubMed]
  16. Guliani, B.P.; Bhalla, A.; Naik, M.P. Association of the severity of meibomian gland dysfunction with dyslipidemia in Indian population. Indian J. Ophthalmol. 2018, 66, 1411–1416. [Google Scholar] [PubMed]
  17. Hu, J.Y.; Liao, Y.; Huang, C.H.; Wang, S.; Liu, Z.G. Association between meibomian gland dysfunction and body mass index in Chinese adults. Zhonghua Yi Xue Za Zhi 2021, 101, 2514–2518. [Google Scholar] [PubMed]
  18. Osae, E.A.; Steven, P.; Redfern, R.; Hanlon, S.; Smith, C.W.; Rumbaut, R.E.; Burns, A.R. Dyslipidemia and Meibomian Gland Dysfunction: Utility of Lipidomics and Experimental Prospects with a Diet-Induced Obesity Mouse Model. Int. J. Mol. Sci. 2019, 20, 3505. [Google Scholar] [CrossRef]
  19. Patel, P.S.; Buras, E.D.; Balasubramanyam, A. The role of the immune system in obesity and insulin resistance. J. Obes. 2013, 2013, 616193. [Google Scholar] [CrossRef]
  20. Bu, J.; Yu, J.; Wu, Y.; Cai, X.; Li, K.; Tang, L.; Jiang, N.; Jeyalatha, M.V.; Zhang, M.; Sun, H.; et al. Hyperlipidemia Affects Tight Junctions and Pump Function in the Corneal Endothelium. Am. J. Pathol. 2020, 190, 563–576. [Google Scholar] [CrossRef] [PubMed]
  21. Bu, J.; Wu, Y.; Cai, X.; Jiang, N.; Jeyalatha, M.V.; Yu, J.; He, X.; He, H.; Guo, Y.; Zhang, M.; et al. Hyperlipidemia induces meibomian gland dysfunction. Ocul. Surf. 2019, 17, 777–786. [Google Scholar] [CrossRef]
  22. Guzzardi, M.A.; Iozzo, P. Brain functional imaging in obese and diabetic patients. Acta. Diabetol. 2019, 56, 135–144. [Google Scholar] [CrossRef] [PubMed]
  23. Laird, A.R.; Fox, P.M.; Eickhoff, S.B.; Turner, J.A.; Ray, K.L.; McKay, D.R.; Glahn, D.C.; Beckmann, C.F.; Smith, S.M.; Fox, P.T. Behavioral interpretations of intrinsic connectivity networks. J. Cogn. Neurosci. 2011, 23, 4022–4037. [Google Scholar] [CrossRef]
  24. Kamali, A.; Hasan, K.M.; Adapa, P.; Keser, A.R.A.; Lincoln, J.; Kramer, L.A. Distinguishing and quantification of the human visual pathways using high-spatial-resolution diffusion tensor tractography. Magn. Reson. Imaging 2014, 32, 796–803. [Google Scholar] [CrossRef]
  25. Fan, H.; Yang, X.; Zhang, J.; Chen, Y.; Li, T.; Ma, X. Analysis of voxel-mirrored homotopic connectivity in medication-free, current major depressive disorder. J. Affect. Disord. 2018, 240, 171–176. [Google Scholar] [CrossRef] [PubMed]
  26. Zuo, X.N.; Kelly, C.; Di Martino, A.; Mennes, M.; Margulies, D.S.; Bangaru, S.; Grzadzinski, R.; Evans, A.C.; Zang, Y.-F.; Castellanos, F.X. Growing together and growing apart: Regional and sex differences in the lifespan developmental trajectories of functional homotopy. J. Neurosci. 2010, 30, 15034–15043. [Google Scholar] [CrossRef]
  27. Peng, J.; Yao, F.; Li, Q.; Ge, Q.; Shi, W.; Tang, L.; Pan, Y.; Liang, R.; Zhang, L.; Shao, Y. Alternations of interhemispheric functional connectivity in children with strabismus and amblyopia: A resting-state fMRI study. Sci. Rep. 2021, 11, 15059. [Google Scholar] [CrossRef] [PubMed]
  28. Ye, L.; Wei, R.; Huang, X.; Shi, W.-Q.; Yang, Q.-C.; Yuan, Q.; Zhu, P.-W.; Jiang, N.; Li, B.; Zhou, Q.; et al. Reduction in interhemispheric functional connectivity in the dorsal visual pathway in unilateral acute open globe injury patients: A resting-state fMRI study. Int. J. Ophthalmol. 2018, 11, 1056–1060. [Google Scholar]
  29. Shi, W.Q.; Liu, J.X.; Yuan, Q.; Ye, L.; Su, T.; Jiang, N.; Lin, Q.; Min, Y.-L.; Li, B.; Zhu, P.-W.; et al. Alternations of interhemispheric functional connectivity in corneal ulcer patients using voxel-mirrored homotopic connectivity: A resting state fMRI study. Acta Radiol. 2019, 60, 1159–1166. [Google Scholar] [CrossRef]
  30. Dong, Z.Z.; Zhu, F.Y.; Shi, W.Q.; Shu, Y.Q.; Chen, L.L.; Yuan, Q.; Lin, Q.; Zhu, P.W.; Liu, K.C.; Min, Y.L.; et al. Abnormalities of interhemispheric functional connectivity in individuals with acute eye pain: A resting-state fMRI study. Int. J. Ophthalmol. 2019, 12, 634–639. [Google Scholar] [PubMed]
  31. Mima, T.; Oluwatimilehin, T.; Hiraoka, T.; Hallett, M. Transient interhemispheric neuronal synchrony correlates with object recognition. J. Neurosci. 2001, 21, 3942–3948. [Google Scholar] [CrossRef]
  32. Afshin, A.; Forouzanfar, M.H.; Reitsma, M.B.; Sur, P.; Estep, K.; Lee, A.; Marczak, L.; Mokdad, A.H.; Moradi-Lakeh, M.; Naghavi, M.; et al. Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N. Engl. J. Med. 2017, 377, 13–27. [Google Scholar]
  33. Bandt, S.K.; Werner, N.; Dines, J.; Rashid, S.; Eisenman, L.N.; Hogan, R.E.; Leuthardt, E.C.; Dowling, J. Trans-middle temporal gyrus selective amygdalohippocampectomy for medically intractable mesial temporal lobe epilepsy in adults: Seizure response rates, complications, and neuropsychological outcomes. Epilepsy. Behav. 2013, 28, 17–21. [Google Scholar] [CrossRef]
  34. Liu, X.; Chen, W.; Tu, Y.; Hou, H.; Huang, X.; Chen, X.; Guo, Z.; Bai, G.; Cheng, W. The Abnormal Functional Connectivity between the Hypothalamus and the Temporal Gyrus Underlying Depression in Alzheimer’s Disease Patients. Front. Aging. Neurosci. 2018, 10, 37. [Google Scholar] [CrossRef] [PubMed]
  35. Buckley, M.J.; Gaffan, D.; Murray, E.A. Functional double dissociation between two inferior temporal cortical areas: Perirhinal cortex versus middle temporal gyrus. J. Neurophysiol. 1997, 77, 587–598. [Google Scholar] [CrossRef]
  36. Herath, P.; Kinomura, S.; Roland, P.E. Visual recognition: Evidence for two distinctive mechanisms from a PET study. Hum. Brain Mapp. 2001, 12, 110–119. [Google Scholar] [CrossRef]
  37. Convit, A.; de Asis, J.; de Leon, M.J.; Tarshish, C.Y.; Santi, S.D.; Rusinek, H. Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer’s disease. Neurobiol. Aging 2000, 21, 19–26. [Google Scholar] [CrossRef]
  38. Tsapkini, K.; Frangakis, C.E.; Hillis, A.E. The function of the left anterior temporal pole: Evidence from acute stroke and infarct volume. Brain 2011, 134, 3094–3105. [Google Scholar] [CrossRef]
  39. Sato, W.; Kochiyama, T.; Uono, S.; Matsuda, K.; Usui, K.; Usui, N.; Inoue, Y.; Toichi, M. Motomi Toichi Gamma Oscillations in the Temporal Pole in Response to Eyes. PLoS ONE 2016, 11, e162039. [Google Scholar] [CrossRef] [PubMed]
  40. Wangbing, S.; Yuan, Y.; Chang, L.; Jing, L. The roles of the temporal lobe in creative insight: An integrated review. Think. Reason. 2017, 23, 321–375. [Google Scholar]
  41. Huang, X.; Cai, F.Q.; Hu, P.H.; Zhong, Y.L.; Zhang, Y.; Wei, R.; Pei, C.G.; Zhou, F.Q.; Shao, Y. Disturbed spontaneous brain-activity pattern in patients with optic neuritis using amplitude of low-frequency fluctuation: A functional magnetic resonance imaging study. Neuropsychiatr. Dis. Treat. 2015, 11, 3075–3083. [Google Scholar] [PubMed]
  42. Chhadva, P.; Goldhardt, R.; Galor, A. Meibomian Gland Disease: The Role of Gland Dysfunction in Dry Eye Disease. Ophthalmology 2017, 124, S20–S26. [Google Scholar] [CrossRef] [PubMed]
  43. Tonkonogy, J.; Goodglass, H. Language function, foot of the third frontal gyrus, and rolandic operculum. Arch. Neurol. 1981, 38, 486–490. [Google Scholar] [CrossRef] [PubMed]
  44. Indefrey, P.; Brown, C.M.; Hellwig, F.; Hagoort, P. A neural correlate of syntactic encoding during speech production. Proc. Natl. Acad. Sci. USA 2001, 98, 5933–5936. [Google Scholar] [CrossRef]
  45. Wu, C.; Zheng, Y.; Li, J.; Wu, H.; She, S.; Liu, S.; Ning, Y.; Li, L. Brain substrates underlying auditory speech priming in healthy listeners and listeners with schizophrenia. Psychol. Med. 2017, 47, 837–852. [Google Scholar] [CrossRef]
  46. Verma, G.; Woo, J.H.; Chawla, S.; Wang, S.; Sheriff, S.; Elman, L.B.; McCluskey, L.F.; Grossman, M.; Melhem, E.R.; Maudsley, A.A.; et al. Whole-brain analysis of amyotrophic lateral sclerosis by using echo-planar spectroscopic imaging. Radiology 2013, 267, 851–857. [Google Scholar] [CrossRef]
  47. Subira, M.; Alonso, P.; Segalas, C.; Real, E.; López-Solà, C.; Pujol, J.; Martínez-Zalacaín, L.; Harrison, B.J.; Menchón, J.M.; Cardoner, N.; et al. Brain structural alterations in obsessive-compulsive disorder patients with autogenous and reactive obsessions. PLoS ONE 2013, 8, e75273. [Google Scholar] [CrossRef] [PubMed]
  48. van den Heuvel, O.A.; Veltman, D.J.; Groenewegen, H.J.; Cath, D.C.; van Balkomvan, A.J.L.M.; van Hartskamp, J.; Barkhof, F.; van Dyck, R. Frontal-striatal dysfunction during planning in obsessive-compulsive disorder. Arch. Gen. Psychiatry 2005, 62, 301–309. [Google Scholar] [CrossRef] [PubMed]
  49. Zhang, Y.N.; Huang, Y.R.; Liu, J.L.; Zhang, F.Q.; Zhang, B.Y.; Wu, J.C.; Ma, Y.; Xia, L.; Hao, Y.; Huo, J.W. Aberrant resting-state cerebral blood flow and its connectivity in primary dysmenorrhea on arterial spin labeling MRI. Magn. Reason. Imaging 2020, 73, 84–90. [Google Scholar] [CrossRef]
  50. Petro, N.M.; Gruss, L.F.; Yin, S.; Huang, H.; Miskovic, V.; Ding, M.; Kell, A. Multimodal Imaging Evidence for a Frontoparietal Modulation of Visual Cortex during the Selective Processing of Conditioned Threat. J. Cogn. Neurosci. 2017, 29, 953–967. [Google Scholar] [CrossRef]
  51. Ratan, D.B.; Sina, Z.M.; Hiroshi, O.; Carter, S.O.; James, T.R.; Elysa, W. Diffusion tensor tractography detection of functional pathway for the spread of epileptiform activity between temporal lobe and Rolandic region. Child’s Nerv. Syst. 2010, 26, 185–190. [Google Scholar]
  52. Lin, Y.C.; Shih, Y.C.; Tseng, W.Y.; Chu, Y.H.; Wu, M.T.; Chen, T.F.; Tang, P.F.; Chiu, M.J. Cingulum correlates of cognitive functions in patients with mild cognitive impairment and early Alzheimer’s disease: A diffusion spectrum imaging study. Brain Topogr. 2014, 27, 393–402. [Google Scholar] [CrossRef]
  53. Delano-Wood, L.; Stricker, N.H.; Sorg, S.F.; Nation, D.A.; Jak, A.J.; Woods, S.P.; Libon, D.J.; Delis, D.C.; Frank, L.R.; Lawrence, R.; et al. Posterior cingulum white matter disruption and its associations with verbal memory and stroke risk in mild cognitive impairment. J. Alzheimers Dis. 2012, 29, 589–603. [Google Scholar] [CrossRef]
  54. Takahashi, M.; Iwamoto, K.; Fukatsu, H.; Naganawa, S.; Iidaka, T.; Ozaki, N. White matter microstructure of the cingulum and cerebellar peduncle is related to sustained attention and working memory: A diffusion tensor imaging study. Neurosci. Lett. 2010, 477, 72–76. [Google Scholar] [CrossRef] [PubMed]
  55. Shinoura, N.; Yamada, R.; Tabei, Y.; Shiiode, T.; Itoi, C.; Saito, S.; Midorikawa, A. The right dorsal anterior cingulate cortex may play a role in anxiety disorder and visual function. Neurol. Res. 2013, 35, 65–70. [Google Scholar] [CrossRef]
  56. Tan, G.; Huang, X.; Ye, L.; Wu, A.; He, L.X.; Zhong, Y.L.; Jiang, N.; Zhou, F.Q.; Shao, Y. Altered spontaneous brain activity patterns in patients with unilateral acute open globe injury using amplitude of low-frequency fluctuation: A functional magnetic resonance imaging study. Neuropsychiatr. Dis. Treat. 2016, 12, 2015–2020. [Google Scholar] [PubMed]
  57. Shi, W.Q.; He, Y.; Li, Q.H.; Tang, L.Y.; Li, B.; Lin, Q.; Min, Y.L.; Yuan, Q.; Zhu, P.W.; Liang, R.B. Central network changes in patients with advanced monocular blindness: A voxel-based morphometric study. Brain Behav. 2019, 9, e1421. [Google Scholar] [CrossRef] [PubMed]
  58. Cavanna, A.E.; Trimble, M.R. The precuneus: A review of its functional anatomy and behavioural correlates. Brain 2006, 129, 564–583. [Google Scholar] [CrossRef] [PubMed]
  59. Wallentin, M.; Weed, E.; Ostergaard, L.; Mouridsen, K.; Roepstorff, A. Accessing the mental space-Spatial working memory processes for language and vision overlap in precuneus. Hum. Brain Mapp. 2008, 29, 524–532. [Google Scholar] [CrossRef]
  60. Horvath, A.; Kiss, M.; Szucs, A.; Kamondi, A. Precuneus-Dominant Degeneration of Parietal Lobe Is at Risk of Epilepsy in Mild Alzheimer’s Disease. Front. Neurol. 2019, 10, 878. [Google Scholar] [CrossRef]
  61. Xiao, J.X.; Xie, S.; Ye, J.T.; Liu, H.H.; Gan, X.L.; Gong, G.L.; Jiang, X.X. Detection of abnormal visual cortex in children with amblyopia by voxel-based morphometry. Am. J. Ophthalmol. 2007, 143, 489–493. [Google Scholar] [CrossRef] [PubMed]
  62. Jiang, J.; Gu, L.; Bao, D.; Hong, S.; He, W.; Tan, Y.; Zeng, X.; Gong, H.; Zhang, D.; Zhou, F. Altered homotopic connectivity in postherpetic neuralgia: A resting state fMRI study. J. Pain Res. 2016, 9, 877–886. [Google Scholar] [CrossRef] [PubMed]
  63. Zhang, P.; Wu, G.W.; Yu, F.X.; Liu, Y.; Li, M.Y.; Wang, Z.; Ding, H.Y.; Li, X.S.; Wang, H.; Jin, M.; et al. Abnormal Regional Neural Activity and Reorganized Neural Network in Obesity: Evidence from Resting-State fMRI. Obesity 2020, 28, 1283–1291. [Google Scholar] [CrossRef]
  64. Syan, S.K.; Mcintyre-Wood, C.; Minuzzi, L.; Hall, G.; McCabe, R.E.; MacKillop, J. Dysregulated resting state functional connectivity and obesity: A systematic review. Neurosci. Biobehav. Rev. 2021, 131, 270–292. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Typical sarcoid manifestations in healthy subjects (A) and patients (PAT) (C). The ducts of the meibomian gland of the healthy subject are patent as seen by corneal confocal microscopy (B), whereas the ducts of the meibomian gland of the PAT appear significantly obstructed (D).
Figure 1. Typical sarcoid manifestations in healthy subjects (A) and patients (PAT) (C). The ducts of the meibomian gland of the healthy subject are patent as seen by corneal confocal microscopy (B), whereas the ducts of the meibomian gland of the PAT appear significantly obstructed (D).
Brainsci 12 01078 g001
Figure 2. Optical coherence tomography angiography (OCTA) examination of PAT and HCs shows that PAT presented an increase in retinal thickness (D) and in fundus vessels (E), and a reduction in macular area (F) compared to HCs (AC).
Figure 2. Optical coherence tomography angiography (OCTA) examination of PAT and HCs shows that PAT presented an increase in retinal thickness (D) and in fundus vessels (E), and a reduction in macular area (F) compared to HCs (AC).
Brainsci 12 01078 g002
Figure 3. Possible mechanisms of MGD in morbidly obese patients.
Figure 3. Possible mechanisms of MGD in morbidly obese patients.
Brainsci 12 01078 g003
Figure 4. The results of VMHC analysis. Notes: The areas of the brain that show altered VMHC values are labelled on the figure. In (A,B), red indicates that the PAT group exhibited higher VMHC values than the HCs and the decrease in VMHC values is indicated in blue. The results of the measurement of VMHC values between the two groups, as represented by the bar chart, are presented in (C). Abbreviations: HCs, healthy controls; PAT, patients.
Figure 4. The results of VMHC analysis. Notes: The areas of the brain that show altered VMHC values are labelled on the figure. In (A,B), red indicates that the PAT group exhibited higher VMHC values than the HCs and the decrease in VMHC values is indicated in blue. The results of the measurement of VMHC values between the two groups, as represented by the bar chart, are presented in (C). Abbreviations: HCs, healthy controls; PAT, patients.
Brainsci 12 01078 g004
Figure 5. ROC curve. The AUCs were: 0.924 for Temporal-Inf, 0.979 for Temporal-Pole-Mid, 0.965 for Rolandic-Oper, and 0.951 for Temporal-Mid.
Figure 5. ROC curve. The AUCs were: 0.924 for Temporal-Inf, 0.979 for Temporal-Pole-Mid, 0.965 for Rolandic-Oper, and 0.951 for Temporal-Mid.
Brainsci 12 01078 g005
Figure 6. Correlation analysis results. Notes: Red indicates positive correlations; blue indicates negative correlations.
Figure 6. Correlation analysis results. Notes: Red indicates positive correlations; blue indicates negative correlations.
Brainsci 12 01078 g006
Figure 7. The association between abnormal activity in brain areas and clinical presentation. Notes: Patients exhibit altered VMHC values in specific brain regions that may be associated with a tendency to anxiety, impaired visual acuity, and lower MMSE score.
Figure 7. The association between abnormal activity in brain areas and clinical presentation. Notes: Patients exhibit altered VMHC values in specific brain regions that may be associated with a tendency to anxiety, impaired visual acuity, and lower MMSE score.
Brainsci 12 01078 g007
Table 1. Basic information of all participants.
Table 1. Basic information of all participants.
ConditionPATHCst-Valuep-Value
Male/female4/86/6N/A0.680
Age (years)34.25 ± 7.3831.67 ± 6.240.9250.365
VA-L (log MAR)0.80 ± 0.170.23 ± 3.5410.972<0.001
VA-R (log MAR)0.83 ± 0.230.21 ± 0.088.867<0.001
Blood pressure
SP (mmHg)126.67 ± 11.85130.50 ± 10.83−0.8270.417
DP(mmHg)82.41 ± 7.6776.17 ± 10.571.6580.112
MMSE score21.42 ± 4.5627.83 ± 2.52−4.266<0.001
TG2.41 ± 1.201.62 ± 0.292.2310.045
Notes: Independent t-tests comparing two groups (p < 0.05 represented statistically significant differences). Abbreviations: PAT, patient; HCs, healthy controls; VA, visual acuity; N/A, not applicable; SP, Systolic blood pressure; DP, Diastolic blood pressure; MMSE, Mini-mental status examination scale; TG, triglyceride.
Table 2. Brain regions presented alteration VMHC value with statistical significance.
Table 2. Brain regions presented alteration VMHC value with statistical significance.
Brain AreasMNI CoordinatesBAPeak Voxelst-Value
XYZ
HCs > PAT
Temporal_Inf−57−36−27373018.85
Temporal_Pole_Mid573−36211536.59
Rolandic_Oper45−1815134776.55
Temporal_Mid−27−783221255.29
HCs < PAT
Cingulum_Ant30932554−11.23
Precuneus−3−63337735−9.58
Notes: The p < 0.05 voxel-level statistical threshold for multiple comparisons as using Gaussian random field (GRF) theory (cluster > 100 voxels, FDR corrected; z > 2.3, p < 0.01). Abbreviation: VMHC, voxel-mirrored homotopic connectivity; HCs: healthy controls; PAT, patient; MNI, Montreal Neurological Institute; BA, Brodmann area.
Table 3. Brain regions with changed VMHC values and its potential impact.
Table 3. Brain regions with changed VMHC values and its potential impact.
Brain RegionBrain FunctionProspective Result
HCs > PAT
Temporal_InfSuperior perceptual processing; Visual comprehensions; Visual object recognition.Visual pathway damaged.
Temporal_Pole_MidRelationship between object naming and auditory comprehension; Later period of eye presence.Abnormal eye movement.
Rolandic_OperLinguistic process; Utterance syntax encoding.Possible impairment of speech function; Being influenced by temporal gyrus.
Temporal_MidAssociation processes; Construction of novel and useful information; Selective processing of conditioned threat in the visual cortex.Impaired cognitive function.
HCs < PAT
Cingulum_AntAdvanced activities (e.g., cognition, memory, and attention retention); Visual cognition.Visual impairment.
PrecuneusPart of DMN; Visual network composition; Regulation of visually relevant spatial imaging and visual motionVisual impairment.
Abbreviation: HC, healthy controls, PAT, patient, DMN, default mode network.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Shi, Y.-D.; Shu, H.-Y.; Liu, L.-Q.; Li, S.-Q.; Liao, X.-L.; Pan, Y.-C.; Su, T.; Zhang, L.-J.; Kang, M.; Ying, P.; et al. Voxel-Mirrored Homotopic Connectivity Is Altered in Meibomian Gland Dysfunction Patients That Are Morbidly Obese. Brain Sci. 2022, 12, 1078. https://doi.org/10.3390/brainsci12081078

AMA Style

Shi Y-D, Shu H-Y, Liu L-Q, Li S-Q, Liao X-L, Pan Y-C, Su T, Zhang L-J, Kang M, Ying P, et al. Voxel-Mirrored Homotopic Connectivity Is Altered in Meibomian Gland Dysfunction Patients That Are Morbidly Obese. Brain Sciences. 2022; 12(8):1078. https://doi.org/10.3390/brainsci12081078

Chicago/Turabian Style

Shi, Yi-Dan, Hui-Ye Shu, Li-Qi Liu, Shi-Qi Li, Xu-Lin Liao, Yi-Cong Pan, Ting Su, Li-Juan Zhang, Min Kang, Ping Ying, and et al. 2022. "Voxel-Mirrored Homotopic Connectivity Is Altered in Meibomian Gland Dysfunction Patients That Are Morbidly Obese" Brain Sciences 12, no. 8: 1078. https://doi.org/10.3390/brainsci12081078

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop